CASE REPORT | VOLUME 5, ISSUE 7 | OPEN ACCESS DOI: 10.23937/2378-3656/1410222

A Rare Case of Symptomatic Factor XII Deficiency Manifesting as Intraventricular Haemorrhage and Hydrocephalus in a Term Neonate

Jayant Kumar Muduli and Meenakshi Mitra

IQ City Medical College and Narayana Multi-speciality Hospital, Durgapur, India

*Corresponding author: Meenakshi Mitra, IQ City Medical College and Narayana Multi-speciality Hospital, JD 5, 54 C, I Q City Campus, Bijra, Sovapur Village, Durgapur 713206, India, Tel: 91-90401-68480, E-mail: mmmixie@gmail.com

Accepted: July 02, 2018 | Published: July 04, 2018

Citation: Muduli JK, Mitra M (2018) A Rare Case of Symptomatic Factor XII Deficiency Manifesting as Intraventricular Haemorrhage and Hydrocephalus in a Term Neonate. Clin Med Rev Case Rep 5:222. doi.org/10.23937/2378-3656/1410222

Copyright: © 2018 Muduli JK, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract


Background

Factor XII (Hageman Factor) is the initiating factor for the Intrinsic Pathway of Coagulation cascade. Literature describing bleeding tendencies in Factor XII deficiency is scarce.

Case

An 18-day-old boy presented with symptoms suggestive of raised intracranial tension and new onset convergent squint. CT scan revealed intraventricular bleeding with hydrocephalus. Platelet count, PT and aPTT were within normal limits. Coagulation profile revealed severe factor XII deficiency.

Keywords


Factor XII deficiency, Intraventricular haemorrhage, Hydrocephalus

Standard Abbreviation


PT: Prothrombin Time; aPTT: Activated Partial Thromboplastin Time; INR: International Normalised Ratio

Introduction


Factor XII (FXII) deficiency, which is also known as Hageman factor deficiency, was first described in the medical literature by Dr. Oscar Ratnoff and Dr. Jane Colopy in 1955. It has an Autosomal Recessive inheritance. The precise incidence of the disorder in the common population is still unknown, but it is found approximately one in a million [1].

FXII plays a dual role in the cascade reactions of coagulation. It can stimulate FXI, which, in turn, activates FIX (previous intrinsic pathway). Factor XII auto activates by contact with a variety of artificial or biologic negatively charged surfaces (activation of contact), resulting in blood coagulation and activation of the inflammatory kallikrein - kinin and complement systems. Most biologic surfaces that activate factor XII become expressed in disease states, though the major function of factor XII is the initiation of fibrinolysis and clot stability [2,3].

Asymptomatic prolongation of aPTT is the most commonly reported manifestation of factor XII deficiency [4]. Immune Thrombocytopenic Purpura like picture was described by Kumar, et al. [5]. Association with congenital abnormalities [6] and ischemic strokes have also been reported [7,8]. Factor XII deficiency has been associated with recurrent abortions in pregnant women [9,10]. Literature describing bleeding tendencies in Factor XII deficiency is scarce.

Trauma and perinatal asphyxia are the most common causes of Intraventricular Haemorrhage in term neonates [11,12]. Though Haemophilia B has been described to cause extracranial bleed [13], coagulation factor deficiencies have rarely been described as the etiology for intraventricular haemorrhage in this age group.

In this article we report a rare case of intraventricular haemorrhage and hydrocephalus secondary to Factor XII deficiency in a term neonate.

Case


An 18-day-old term boy baby with a birth weight of 3 kg, presented with refusal of feeds, shrill cry, intermittent stiffening of limbs and new onset squint. The mother had history of recurrent abortions. Otherwise, the antenatal history was insignificant. Examination revealed increased tone, bulging anterior fontanelle, sutural diastasis and convergent squint. Lumbar puncture resulted in haemorrhagic tap. CT scan revealed intraventricular bleeding with hydrocephalus (Figure 1). Blood, urine and cerebrospinal fluid culture were negative. Normal platelet count, PT and aPTT reports were normal. Coagulation profile revealed severe factor XII deficiency (Observed value: 33.1%). Mixing studies were done, results were negative. Other coagulation factor values were within normal levels. This case was managed conservatively till hemodynamic stability was achieved and referred for definitive management of the hydrocephalus.

Figure 1: Grade III Intraventricular haemorrhage with dilation of ventricles. Reference: Department of Pediatrics, IQ City Medical College and Narayana Multi-specialty Hospital, CT Scan done on 5/4/2018. View Figure 1

Discussion


The baby did not have any history of perinatal asphyxia or birth trauma. Thus congenital thrombocytopenia and coagulopathy were the next possibilities. However, the platelet count and PT, aPTT and INR reports were within normal limits. This prompted the team to investigate for other coagulation factors of which factor XII which was deficient. The mother was asked to get her factor XII assay done in view of bad obstetric history.

Intraventricular haemorrhage secondary to Haemophilia B has been described by Bhattacharya, et al. [14]. But extensive literature search could not locate Factor XII deficiency as an etiology for Intraventricular haemorrhage.

Severe deficiency of factor XII in this baby may have caused abnormalities in intrinsic pathway leading to intraventricular haemorrhage.

Conclusion


Factor XII deficiency is asymptomatic with in-vitro prolongation of aPTT. We would like to conclude by emphasizing that factor XII deficiency may also present with haemorrhagic manifestations as in our case.

Disclaimer


None.

Sources of Support


None.

Declaration on Competing Interests


None.

References


  1. Colman RW (2003) Factor XII Deficiency. NORD Guide to Rare Disorders, Lippincott, Williams & Wilkins, Philadelphia, PA, 382-383.

  2. Arphan Azaad M, Zhang Q, Li Y (2015) Factor XII (Hageman factor) Deficiency: A Very Rare Coagulation Disorder. Open Journal of Blood Diseases 5: 39-42.

  3. Schmaier AH (2008) The elusive physiologic role of factor XII. J Clin Invest 118: 3006-3009.

  4. Al-Harbi I, Althobaiti AS, Alahmadi EH (2017) Saudi boy with Factor XII Deficiency. International Journal of Healthcare Sciences 4: 644-646.

  5. Kumar R, Gupta A, Mathur P, Garg M (2016) Factor XII deficiency- A rare coagulation disorder. Indian J Child Health 3: 349-350.

  6. Malbora B, Derbent M, Ozbek N (2017) Rare coagulation factor deficiencies associated with congenital abnormalities. J Clin Case Rep 7: 932.

  7. Foncea N, Gomez Beldarrain M, Ruiz Ojeda J, Carrascosa T, Garcia-Monco J (2001) Ischemic stroke in a patient with factor XII (Hageman) deficiency. Neurologia 16: 227-228.

  8. Pham M, Stoll G, Nieswandt B, Bendszus M, Kleinschnitz C (2012) Blood coagulation factor XII- A neglected player in stroke pathophysiology. J Mol Med (Berl) 90: 119-126.

  9. Pauer H, Burfeind P, Kostering H, Emons G, Hinney B (2003) Factor XII deficiency is strongly associated with primary recurrent abortions. Fertility and Sterility 80: 590-594.

  10. Ozgu-Erdinc AS, Togrul C, Aktulay A, Buyukkagnici U, Eyi EGY, et al. (2014) Factor XII levels in Women with Recurrent Pregnancy Loss. Journal of Pregnancy 2014: 1-3.

  11. Soul JS (2012) Intracranial Hemorrhage. In: Cloherty JP, Eichenwald EC, Hansen AR, Stark AR, Manual of Neonatal Care. (7th edn), Wolters Kluwer, India, 686-710.

  12. Al Yazidi G, Boudes E, Tan X, Saint-Martin C, Shevell M, et al. (2015) Intraventricular hemorrhage in asphyxiated newborns treated with hypothermia: A look into incidence, timing and risk factors. BMC Pediatr 15: 106.

  13. Ferreira N, Proenca E, Gordinho C, Oliveira D, Guedes A, et al. (2015) Neonatal hemophilia: A rare presentation. Pediatr Rep 7: 6338.

  14. Bhattacharya D, Sharawat IK, Saini L (2018) Intraventricular haemorrhage and obstructive hydrocephalus in a term neonate: an uncommon presentation of haemophilia. BMJ Case Rep 2018.